Orca Bio at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Orca Bio exhibits at Booth 2029 at ASH 2026 in New Orleans. Orca Bio supports a symposium on managing myelodysplastic syndromes in the modern era. The program is about getting ahead of the disease with current approaches.
| Organization | ASH 2026 Attendance |
|---|---|
Orca Bio Menlo Park, CA | |
Late-stage company developing high-precision allogeneic T-cell immunotherapies, led by Orca-T in a Phase 3 trial for blood cancers. | Booth Exhibiting at Booth 2029 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 3:00pm–6:00pm MDS in the Modern Era: Getting Ahead of the 8-Ball Moving myelodysplastic syndrome care toward early disease-modifying drugs, with hypomethylating agents for higher-risk disease and wider transplant access. |
Instantly find 20 buyers from Orca Bio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction